Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Kit used for diagnosing acute exacerbation period of chronic obstructive pulmonary disease

A technology for chronic obstructive pulmonary disease and acute exacerbation, applied in the biological field, can solve the problem of incomplete understanding of the pathogenesis of chronic obstructive pulmonary disease, and achieve the effect of simple, easy and reliable protein expression level.

Inactive Publication Date: 2011-11-23
ZHONGSHAN HOSPITAL FUDAN UNIV
View PDF4 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The pathogenesis of chronic obstructive pulmonary disease is not fully understood

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Kit used for diagnosing acute exacerbation period of chronic obstructive pulmonary disease

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0017] A kit for diagnosing the acute exacerbation of chronic obstructive pulmonary disease, comprising the following reagents:

[0018] 1. Interleukin 9 (manufactured by American R&D Systems, model MAB209) and its enzyme-labeled antibody (manufactured by American R&D Systems, model BAF209);

[0019] 2. Macrophage-derived chemokine (manufactured by American R&D Systems, model MAB336) and its enzyme-labeled antibody (manufactured by American R&D Systems, model BAF336);

[0020] 3. Interleukin-18 binding protein A (produced by R&D Systems, USA, model MAB1192) and its enzyme-labeled antibody (produced by R&D Systems, USA, model BAF119);

[0021] 4. C-C sequence ligand 28 (produced by R&D Systems, USA, model MAB7171) and its enzyme-labeled antibody (produced by R&D Systems, USA, model BAF717);

[0022] 5. Monocyte chemoattractant protein-3 (manufactured by American R&D Systems, model MAB282) and its enzyme-labeled antibody (manufactured by American R&D Systems, model BAF282);

...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a kit used for diagnosing the acute exacerbation period of chronic obstructive pulmonary disease. The kit comprises a cell factor and an enzyme labeled antibody thereof and is characterized in that the cell factor is interleukin 9, interleukin 18 binding protein A, C-C sequence ligand 28, a human skin T cell capture chemokine, a Beta cytokine, a monocyte chemoattractant protein-3, a monocyte chemoattractant protein-4, a lymphotoxin induced protein entering the T cell, a macrophage-derived chemokine, a human bone marrow suppression factor 1, a human macrophage stimulating protein, an osteopontin and a human thymus expressed chemokine. The invention firstly proposes that the cell factor can be used as a leading indicator for diagnosis of the acute exacerbation period of the chronic obstructive pulmonary disease.

Description

technical field [0001] The invention relates to a kit for diagnosing acute exacerbation of chronic obstructive pulmonary disease, which belongs to the field of biotechnology. Background technique [0002] Chronic obstructive pulmonary disease (COPD) is a lung disease characterized by persistent obstruction of airflow from the lungs. The disease is an underdiagnosed, life-threatening lung disease that impedes normal breathing and is not fully reversible. Its main clinical manifestations are cough, sputum production and dyspnea. As the course of the disease progresses, it can develop to also feel short of breath when walking on a flat road. Some patients have wheezing symptoms. In addition, there are systemic symptoms such as fatigue, anorexia, and weight loss. Respiratory failure or heart failure may cause corresponding symptoms during the acute attack. Because of its large number of patients, high mortality rate and heavy social and economic burden, it has become an im...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): G01N33/68G01N33/577
Inventor 白春学王向东陈弘
Owner ZHONGSHAN HOSPITAL FUDAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com